布鲁克林资本已重申其对Lisata Therapeutics的买入评级,彰显对该股的持续信心。更多详情可通过相关链接获取。此消息发布于2025年7月15日。https://www.benzinga.com/quote/LSTA/analyst-ratings
布鲁克林资本已重申其对Lisata Therapeutics的买入评级,彰显对该股的持续信心。更多详情可通过相关链接获取。此消息发布于2025年7月15日。https://www.benzinga.com/quote/LSTA/analyst-ratings
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.